DAIPT is a neurologic disorder characterized by skeletal contractures and a marked decrease in the ability to perceive touch, vibration or proprioception. Affected individuals also suffer from sensory ataxia, walking difficulties, dysmetria, dysarthria, impaired fine motor skills, areflexia, hypotonia and muscle weakness. Neurological investigations reveal mild sensory axonal neuropathy and reduced amplitude of sensory nerve action potentials. Other symptoms include short stature, neonatal respiratory insufficiency, scoliosis, congenital hip dysplasia, hand and foot deformities, and facial dysmorphia such as a long nose with a wide nasal bridge, a thin upper lip, a high arched palate and myopathic facies.
The condition has an onset in the first decade of life. DAIPT is a rare disease and only a handful of cases have been reported thus far. There is hence limited knowledge on the prevalence and prognosis of the disorder. It is, however, a progressive condition, and symptoms such as skeletal contractures and neuropathy are expected to worsen over time.
The condition can be diagnosed based on clinical investigations such as an algometer to measure the pain threshold, an esthesiometer for skin tactile sensitivity and a Peltier-based thermode to measure the threshold for thermal pain detection. There is currently no cure for the disorder, and treatment is focused on symptomatic support.
The disorder follows an autosomal recessive pattern of inheritance and is caused by homozygous or compound heterozygous mutations in the PIEZO2 gene. This gene encodes a component of a mechanosensitive cation channel and is essential for the rapid adaptation of mechanically-activated currents in somatosensory neurons. It plays a key role in perceiving touch and proprioception. Mutations in the gene associated with DAIPT mainly include nonsense variants and deletions that cause frameshift and premature truncation, often resulting in a non-functioning PIEZO2 protein.
Monies et al. (2017) outlined the findings of 1000 diagnostic panels and exomes carried out at a next generation sequencing lab in Saudi Arabia. One patient, a 12-year-old female from a consanguineous family, suffered from severe lower limb weakness, progressive scoliosis and suspected spinal muscular atrophy but did not have arthrogryposis. She also reported a family history of this phenotype. Using whole exome sequencing, a homozygous mutation (c.273_279del, p.A91fs) was identified in exon 3 of the patient’s PIEZO2 gene, associated with DAIPT. Given the atypical presentation of the patient, this case helped in the phenotypic expansion of the disorder.
View PDF version of Arthrogryposis, Distal, with Impaired Proprioception and Touch
To contribute with your findings to the content of this record, please fill the CTGA Database Information Submission Form and email it, along with supportive documents, to firstname.lastname@example.org.